GORE PROPATEN Vascular Graft vs. Disadvantaged Autologous Vein Graft

NCT00617279 · clinicaltrials.gov ↗

PHASE4

Phase

TERMINATED

Status

31

Enrollment

INDUSTRY

Sponsor class

Stopped Study terminated due to low enrollment

Conditions

Peripheral Arterial Occlusive Disease

Interventions

DEVICE: GORE PROPATEN Vascular Graft
PROCEDURE: Disadvantaged Autologous Vein Graft

Sponsor

W.L.Gore & Associates